Loading…
GRFS
Grifols SA
NASDAQ· Healthcare· Drug Manufacturers - General· CUSIP 398438408
$7.45-0.67%Price as of Oct 23, 00:46 UTC · updated once a day, after the close
At a glance
Grifols SA (GRFS) is listed on NASDAQ and classified in Drug Manufacturers - General, part of the Healthcare sector. It is headquartered in Barcelona, Spain and has 25,258 employees. The company is worth $5.07B and trades at 9.7x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was €7.52B in fiscal 2025, up 4.3% from the year before. Net income was €402M. The share price is 24.7% below its 52-week high of $9.90. It pays a dividend yielding 1.48%. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Israel Englander (Millennium Management), at $30.94M. In that quarter, 1 of them reduced the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $5.07B
- P/E
- 9.7x
- Forward P/E
- 5.2x
- P/B
- 1.6x
- Dividend yield
- 1.48%
- Payout
- 14.29%
- EPS
- $0.77
- ROE
- 6.93%
- Profit margin
- 6.09%
- Revenue growth
- -0.90%
- Beta
- 1.20
- 52-week high
- $9.90
- 52-week low
- $6.96
History
Year by year, from the annual reports; dividends from the payments themselves.
Revenue, debt and profit are in EUR, the currency the company reports in — not converted to dollars. Dividends are in dollars.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -28.8% over 5Y.
today you would have $600.40▼ -40.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $9.35 | $7.44 | $11.56 | $8.50 | |
| EPS | €0.59 | €0.23 | €0.09 | €0.31 | |
| Dividend yield | — | 1.85% | — | — | — |
| Profit margin | 2.61% | 5.34% | 2.18% | 0.64% | 3.05% |
| ROE | 2.97% | 7.63% | 2.67% |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
$8.90
Square root of 22.5 × earnings × book value. Blind to intangibles, so it undervalues software and brands.
Earnings
$1.14
Earnings growing 0.0% a year plus a 1.5% dividend yield. Growth capped at 25%.
Earnings
$18.70
Median P/E of 24.3 among peers in the sector.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Dividends
—
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CONConcentra Group Holdings Parent, Inc. | $39.97 | 25.3x | 10.7x | 0.63% | 47.06% | $5.1B |
| SRRKScholar Rock Holding Corp | $41.96 | — | 20.1x | 0.00% | -167.77% | $5.11B |
| BLLNBillionToOne, Inc. | $105.68 | 167.7x | 9.2x | 0.00% | 10.68% | $4.99B |
| SHCSotera Health Co |
About the company
- 25,258
- Barcelona, Spain